When was Samsara Vision founded?

Samsara Vision was founded in 1997 and raised its 1st funding round 8 years after it was founded.

Where is Samsara Vision located?

Samsara Vision is headquartered in Far Hills, United States.

Who is the current CEO of Samsara Vision?

Thomas Ruggia of Samsara Vision.

How many employees does Samsara Vision have?

As of Sep 30, 2026, the latest employee count at Samsara Vision is 39.

Is Samsara Vision a funded company?

Samsara Vision is a funded company, having raised a total of $55M across 4 funding rounds to date. The company's 1st funding round was a $***** Series D round, raised on Jan 07, 2005.

When was the latest funding round of Samsara Vision?

Samsara Vision's latest funding was a $***** Conventional Debt round on Sep 13, 2013, with participation from 1 investor.

Where does Samsara Vision rank among its competitors?

Samsara Vision ranks 2nd amongst 10 active competitors, of which 3 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was Science, which secured $230M in Feb, 2026.

Who are the top competitors of Samsara Vision?

Samsara Vision's top competitors include Science, Espansione Group and Oculox Technologies. Among them, Science secured the most recent funding round in February, 2026.

Samsara Vision - 2026 Company Profile, Team, Funding & Competitors

Company Details

Provider of a specialty medical device company focusing on the development, manufacturing, and marketing of proprietary implantable ophthalmic devices designed to improve central vision for late-stage age-related macular degeneration (AMD) patients.

Website: www.samsaravision.com/
Social
Email ID: *****@samsaravision.com
Phone Number: +1 **********

Key Metrics

Founded Year

1997

Location

Far Hills, United States

Stage

Series E

Total Funding

$55M in 4 rounds

Latest Funding Round

Conventional Debt, Sep 13, 2013, $*****

Investors

Saints Capital & 10 more

Ranked

2^nd among 10 active competitors

Employee Count

39 as on Sep 30, 2026

Similar Companies

Science & 8 more

View Samsara Vision's full profile

Samsara Vision is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
Samsara Vision, Inc. CIN: 5824285 , United States, Active	Sep 29, 2015	-	-	-

Samsara Vision has raised a total funding of $55M over 4 rounds. Its first funding round was on Jan 07, 2005. Its latest funding round was a Conventional Debt round on Sep 13, 2013 for $*****. 1 investor participated in its latest round. Samsara Vision has 11 institutional investors.

Here is the list of recent funding rounds of Samsara Vision:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 13, 2013	4273480	Conventional Debt	3162724	9714473	6214234	9337934
Feb 05, 2012	3807745	Series E	6384890	4338728	3402251	Giza Venture Capital & 6 more
Jan 10, 2011	2791598	Series E	1563621	3291952	Saints Capital	Giza Venture Capital & 4 more

Access funding benchmarks and valuations. Sign up today!

View details of Samsara Vision's funding rounds and investors

Samsara Vision's employee count trend

Samsara Vision has 39 employees as of Sep 26. Here is Samsara Vision's employee count trend over the years:

Uncover Samsara Vision's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Samsara Vision include Science, Espansione Group and Oculox Technologies. Here is the list of Top 10 competitors of Samsara Vision, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Science 2021, Alameda (United States), Series C	Provider of online science magazine	$490M	Khosla Ventures, RAA Capital & 10 others	65/100
2nd	Samsara Vision 1997, Far Hills (United States), Series E	Provider of a specialty medical device company focusing on the development, manufacturing, and marketing of proprietary implantable ophthalmic devices designed to improve central vision for late-stage age-related macular degeneration (AMD) patients	$55M	Saints Capital, Life Sciences Alternative Funding ... & 9 others	50/100
3rd	Espansione Group 1981, Bologna (Italy), Acquired	Developer of Photobiostimulation for various medical applications	-	Europa	39/100
4th	Oculox Technologies 2011, Switzerland, Unfunded	Manufacturer of medical devices for ophthalmological diagnostic and therapeutic procedures	-	-	28/100
5th	Eyful 2019, Montreal (Canada), Funding Raised	Developer of eyeglasses for people affected by macular degeneration	-	-	22/100
6th	Novavido 2021, Bologna (Italy), Funding Raised	Developer of a medical device for retinitis pigmentosa and macular degeneration	-	UTOPIA	20/100
7th	Alpha Ret Fremont (United States), Public	Developer of ophthalmic laser therapy designed to slow AMD progression	-	-	20/100
8th	Nova Oculus Medical 2023, Palm Desert (United States), Seed	Developer of a therapeutic medical device for age-related macular degeneration	$22.5K	-	16/100
9th	Valeda 2013, Poulsbo (United States), Unfunded	Developer of light delivery system intended to improve visual acuity	-	-	16/100
10th	Idea-Amd Germany, Unfunded	Developer of diagnostic and assistive technology for macular degeneration patients	-	-	16/100